531 related articles for article (PubMed ID: 29880963)
1. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
[TBL] [Abstract][Full Text] [Related]
2. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
[TBL] [Abstract][Full Text] [Related]
3. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
[TBL] [Abstract][Full Text] [Related]
4. What impact do Rome IV criteria have on patients with IBS in China?
Wang B; Zhao W; Zhao C; Jin H; Zhang L; Chen Q; Wang B
Scand J Gastroenterol; 2019 Dec; 54(12):1433-1440. PubMed ID: 31829752
[No Abstract] [Full Text] [Related]
5. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
Edwards T; Friesen C; Schurman JV
BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
[TBL] [Abstract][Full Text] [Related]
6. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
7. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
Black CJ; Yiannakou Y; Houghton LA; Ford AC
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
[TBL] [Abstract][Full Text] [Related]
10. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
Simrén M; Törnblom H; Palsson OS; Van Oudenhove L; Whitehead WE; Tack J
Gastroenterology; 2019 Aug; 157(2):391-402.e2. PubMed ID: 31022401
[TBL] [Abstract][Full Text] [Related]
11. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
[TBL] [Abstract][Full Text] [Related]
12. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
Black CJ; Craig O; Gracie DJ; Ford AC
Gut; 2021 Jun; 70(6):1110-1116. PubMed ID: 32973070
[TBL] [Abstract][Full Text] [Related]
14. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
Schurman JV; Karazsia BT; Friesen CA
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.
Aziz I; Palsson OS; Törnblom H; Sperber AD; Whitehead WE; Simrén M
Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):252-262. PubMed ID: 29396034
[TBL] [Abstract][Full Text] [Related]
16. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.
Kosako M; Akiho H; Miwa H; Kanazawa M; Fukudo S
Biopsychosoc Med; 2018; 12():18. PubMed ID: 30534195
[TBL] [Abstract][Full Text] [Related]
17. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome in children with chronic gastrointestinal symptoms in primary care.
Hogervorst EM; Ganzevoort IN; Berger MY; Holtman GA
Fam Pract; 2024 Jun; 41(3):292-298. PubMed ID: 37392047
[TBL] [Abstract][Full Text] [Related]
19. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
[TBL] [Abstract][Full Text] [Related]
20. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
